DOTA-PSMA-EB-01 (Compound LNC1003) is a specific inhibitor of PSMA (IC50= 10.77 nM).DOTA-PSMA-EB-01 enhances the uptake and retention time of 177Lu in tumors[1]. DOTA-PSMA-EB-01 can be used for the synthesis/research of Radionuclide-Drug Conjugates (RDCs).
Molecular Weight:
1883.06
Purity:
97.02
Formula:
C87H115N15O28S2
Target:
PSMA,Radionuclide-Drug Conjugates (RDCs)
Application Notes:
Peptides
* VAT and and shipping costs not included. Errors and price changes excepted
